Finally, we explored the association of tumor cell CXCR3 expression and patient survival in two independent cohorts of HGSC patients.14 In the ‘validation set’ (n=117, Table 1), tumor cell CXCR3 was scored 0 (7/117, 6%), 1+ (44/117, 38%), 2+ (42/117, 36%) and 3+ (24/117, 21%) (‘discovery set’ see above). Here, CXCR3 is linked to neoplasm.